The Effect of Time-Slot Scheduling on Flu Vaccination Rates
Effect of Time-Slot Scheduling on Flu Vaccination Rates
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
Study Type
Study Type
Enrollment (Anticipated)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Pennsylvania
-
Philadelphia, Pennsylvania, United States, 19104
- University of Pennsylvania
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- seasonal influenza vaccine indications according to the CDC
- employees of partner corporations executing study
Exclusion Criteria:
- none
Study Plan
How is the study designed?
Design Details
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Active Comparator: Control
|
Patients were provided with basic information (present in all conditions) about when and where they could receive a flu shot, but they were given no further treatment.
|
|
Experimental: 1 Hour Planning Prompt
|
Patients were prompted to write down a planned date (and in some cases time) for receiving a flu shot.
|
|
Experimental: 2 Hour Planning Prompt
|
Patients were prompted to write down a planned date (and in some cases time) for receiving a flu shot.
|
|
Experimental: 1 Day Planning Prompt
|
Patients were prompted to write down a planned date (and in some cases time) for receiving a flu shot.
|
|
Experimental: Default Planning Prompt
|
Patients were given a suggested date and time for receiving a flu shot.
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Receipt of seasonal influenza vaccination
Time Frame: up to 30 weeks
|
up to 30 weeks
|
Collaborators and Investigators
Sponsor
Sponsor
Collaborators
Collaborators
Investigators
Investigators
- Principal Investigator: Katherine L Milkman, Ph.D., University of Pennsylvania
Study record dates
Study Major Dates
Study Start
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Estimate)
First Posted
Study Record Updates
Last Update Posted (Estimate)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- 810589
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.